Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis. [electronic resource]
- JAMA network open 08 2019
- e198890 p. digital
Acrylonitrile--analogs & derivatives Adult Aged Aged, 80 and over Aniline Compounds--therapeutic use Antineoplastic Combined Chemotherapy Protocols--adverse effects Cardiovascular Diseases--chemically induced Female Humans Male Melanoma--drug therapy Middle Aged Protein Kinase Inhibitors--therapeutic use Proto-Oncogene Proteins B-raf--therapeutic use Randomized Controlled Trials as Topic Skin Neoplasms--drug therapy Young Adult